中国食管鳞癌癌前状态及癌前病变诊治策略专家共识

标题: 中国食管鳞癌癌前状态及癌前病变诊治策略专家共识
title: Chinese expert consensus on diagnosis and management of precancerous conditions and lesions of esophageal squamous cell carcinoma
版本: 原创版
version: Original
分类: 专家共识
classification: Experts consensus
领域: 诊疗
field: Diagnosis and Treatment
国家和地区: 中国
Country and region: China
指南使用者: 消化、消化内镜和健康管理专业医师
Guide users: Practioners in gastroenterology, gastrointestinal endoscopy and health management
证据分级方法: GRADE System
Evidence grading method:
制定单位: 国家消化系疾病临床医学研究中心(上海)
Formulating unit: National Clinical Research Center for Digestive Disease (Shanghai)
注册时间: 2020-09-23
Registration time:
注册编号: IPGRP-2020CN139
Registration number:
指南制订的目的: 我国是食管鳞癌发病率和死亡率最高的国家之一,食管鳞癌疾病负担沉重、防控态势严峻。食管鳞状上皮在癌变前存在癌前状态和癌前病变阶段,早期诊断并合理干预癌前状态和癌前病变有助于提高食管癌早诊率,降低发病率,是食管癌防控工作的重要抓手。美国胃肠病学会、英国胃肠病协会、我国国家消化系统疾病临床医学研究中心均已就食管腺癌癌前病变、癌前状态(巴雷特食管)的诊治和监视制定了指南和共识意见。但对于我国高发的食管鳞癌,其癌前状态及癌前病变的定义、诊断、随访和治疗等关键问题尚未达成共识。
Purpose of the guideline: China is one of the countries with the highest incidence and mortality of esophageal squamous cell carcinoma, and the burden of esophageal squamous cell carcinoma is heavy and the prevention and control situation is severe.Esophageal squamous epithelium has precancerous condition and precancerous lesion stage before cancerization. Early diagnosis and reasonable intervention of precancerous state and precancerous lesion can help to improve the rate of early diagnosis and reduce the incidence of esophageal cancer, which is an important grasp for the prevention and control of esophageal cancer.The American Gastroenterology Society, the British Gastroenterology Association, and the National Center for Clinical Research in Digestive Diseases of China have all developed guidelines and consensus opinions on the diagnosis, treatment, and surveillance of precancerous lesions and precancerous conditions (Barrett's esophagus) of esophageal adenocarcinoma.However, esophageal squamous cell carcinoma, which is more prevalent in China, consensus on the definition, diagnosis, follow-up and treatment of precancerous conditions and other key issues have not been reached.